Synapses and Alzheimer's Disease

Cited by (441)

Items 101–200 of 441

1. Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer's disease
   Wenrui Qu, Baoming Yuan, Rui Li, Qianqian Liu, Xi Zhang, Ranji Cui, Wei Yang, Bingjin Li · 2020 · Cell Proliferation
2. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
   Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, Susanne Gerber · 2020 · Cells
3. Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease
   Thomas Henry Gillingwater, Thomas M. Wishart · 2013 · Neuropathology and Applied Neurobiology
4. Treatment of Alzheimer’s Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions
   John Wesson Ashford · 2015 · Journal of Alzheimer s Disease
5. Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease
   Garry Whitehead, Philip L. Regan, Daniel J. Whitcomb, Kwangwook Cho · 2016 · Neuropharmacology
6. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease
   Giralt, Albert, de Pins, Benoit, Cifuentes-Díaz, Carmen, López-Molina, Laura, Farah, Amel Thamila, Tible, Marion, Deramecourt, Vincent, Arold, Stefan T, Ginés, Silvia, Hugon, Jacques et al. · 2018 · Experimental Neurology
7. The two faces of synaptic failure in AppNL-G-F knock-in mice
   Amira Latif‐Hernandez, Victor Sabanov, Tariq Ahmed, Katleen Craessaerts, Takashi Saito, Takaomi C. Saido, Detlef Balschun · 2020 · Alzheimer s Research & Therapy
8. Long non-coding RNAs in brain development, synaptic biology, and Alzheimer’s disease
   Changhua Shi, Ling Zhang, Chuan Qin · 2017 · Brain Research Bulletin
9. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer’s Disease in APP/PS1 Transgenic Mouse
   Honghai Hong, Yang Li, Baochang Su · 2017 · Journal of Alzheimer s Disease
10. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
    Park, Jong-Chan, Han, Sun-Ho, Cho, Hyun Jin, Byun, Min Soo, Yi, Dahyun, Choe, Young Min, Kang, Seokjo, Jung, Eun Sun, Won, Su Jin, Kim, Eun Hye et al. · 2017 · Alzheimer's Research & Therapy
11. Evidence for altered dendritic spine compartmentalization in Alzheimer’s disease and functional effects in a mouse model
    Alexandre Androuin, Brigitte Potier, U. Valentin Nägerl, Daniel Cattaert, Lydia Danglot, Manon Thierry, Ihsen Youssef, Antoine Triller, Charles J. Duyckaerts, Khalid Hamid El Hachimi et al. · 2018 · Acta Neuropathologica
12. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer’s Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals
    Timothy J. Hark, Nalini R. Rao, Charlotte Castillon, Tamara Basta, Samuel N. Smukowski, Huan Bao, Arun Upadhyay, Ewa K. Bomba-Warczak, Toshihiro Nomura, Eileen T O'Toole et al. · 2020 · Cell Systems
13. Differential Effects of Physical Exercise, Cognitive Training, and Mindfulness Practice on Serum BDNF Levels in Healthy Older Adults: A Randomized Controlled Intervention Study
    Aurélie Ledreux, Krister Håkansson, Roger Carlsson, Mhretab Kidane, Laura Columbo, Yvonne Terjestam, Eliza Ryan, Erich S. Tusch, Bengt G. Winblad, Kirk R. Daffner et al. · 2019 · Journal of Alzheimer s Disease
14. Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer’s disease mouse model
    Laura K. Hamilton, Gaël Moquin‐Beaudry, Chenicka Lyn Mangahas, Federico Pratesi, Myriam Aubin, Anne Aumont, Sandra E. Joppé, Alexandre Légiot, Annick Vachon, Mélanie Plourde et al. · 2022 · Nature Communications
15. Autophagy interaction with herpes simplex virus type-1 infection
    Douglas O’Connell, Chengyu Liang · 2016 · Autophagy
16. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer’s disease
    Burke, Rebecca M., Norman, Timothy A., Haydar, Tarik F., Slack, Barbara E., Leeman, Susan E., Blusztajn, Jan Krzysztof, Mellott, Tiffany J. · 2013 · Proceedings of the National Academy of Sciences
17. Epigenetic regulation by G9a/ GLP complex ameliorates amyloid‐beta 1‐42 induced deficits in long‐term plasticity and synaptic tagging/capture in hippocampal pyramidal neurons
    Mahima Sharma, Tobias Dierkes, Sreedharan Sajikumar · 2017 · Aging Cell
18. Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit
    Sergio L. Angulo, Rena Orman, Samuel A. Neymotin, L. Liu, Luna Buitrago, Efraín Cepeda-Prado, Dimitre G. Stefanov, William W. Lytton, Mark Stewart, Scott A. Small et al. · 2017 · Neurobiology of Disease
19. Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
    Alexey M. Petrov, Marat R. Kasimov, Andrey Lvovich Zefirov · 2017 · Acta Naturae
20. Altered intrinsic excitability of hippocampal CA1 pyramidal neurons in aged PDAPP mice
    Francesco Tamagnini, Janet Novelia, Talitha L. Kerrigan, Jon T. Brown, Krasimira T. Tsaneva-Atanasova, Andrew D. Randall · 2015 · Frontiers in Cellular Neuroscience
21. Complement cascade functions during brain development and neurodegeneration
    Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2021 · FEBS Journal
22. Caspase‐6 as a novel early target in the treatment of Alzheimer's disease
    Andrea Claire LeBlanc · 2013 · European Journal of Neuroscience
23. Role of Liver X Receptor in AD Pathophysiology
    Adrián Gabriel Sandoval-Hernández, Luna Buitrago, Herman Moreno, Gloria Patricia Cardona‐Gómez, Gonzálo Arboleda · 2015 · PLoS ONE
24. Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model
    Yang Li, Ke Zhu, Ning Li, Xiaotong Wang, Xuansheng Xiao, Lijuan Li, Lijuan Li, Ying He, Jinglan Zhang, Jiaoyang Wo et al. · 2021 · Alzheimer s Research & Therapy
25. Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice
    Claire S. Durrant, Michael P. Coleman · 2016 · Molecular Neurodegeneration
26. Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease
    Santiago V. Salazar, Christopher Gallardo, Adam C. Kaufman, Charlotte S. Herber, Laura T. Haas, Sophie Robinson, Jean C. Manson, Michael K. Lee, Stephen M. Strittmatter · 2017 · Journal of Neuroscience
27. Brain-derived neurotrophic factor inhibits hyperglycemia-induced apoptosis and downregulation of synaptic plasticity-related proteins in hippocampal neurons via the PI3K/Akt pathway
    Yuan Zhong, Yitong Zhu, Ting He, Wei Li, Qinjie Li, Ya Miao · 2018 · International Journal of Molecular Medicine
28. Tau acts as a mediator for<scp>A</scp>lzheimer's disease‐related synaptic deficits
    Liao, Dezhi, Miller, Eric C., Teravskis, Peter J. · 2014 · European Journal of Neuroscience
29. Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule
    Vojtěch Vyklický, Barbora Hrčka Krausová, Jiří Černý, Aleš Balík, Martin Zapotocky, Marián Novotný, Katarína Hemelíková, Tereza Smejkalová, Martina Kaniaková, Miloslav Kořı́nek et al. · 2015 · Scientific Reports
30. Fornical Closed-Loop Stimulation for Alzheimer’s Disease
    Sühan Senova, Antoine Chaillet, Andrés M. Lozano · 2018 · Trends in Neurosciences
31. Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease
    Choudhury, Saptamita Paul, Bano, Sarika, Sen, Srijon, Suchal, Kapil, Kumar, Saroj, Nikolajeff, Fredrik, Dey, Sanjay Kumar, Sharma, Vaibhav · 2022 · npj Parkinson's Disease
32. Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
    Juan Manuel Zolezzi, Sussy Bastias Candia, Manuel J. Santos, Nibaldo C. Inestrosa · 2014 · Frontiers in Aging Neuroscience
33. On the research of time past: the hunt for the substrate of memory
    Bridget N. Queenan, Tomás J. Ryan, Michael S. Gazzaniga, Charles Randy Gallistel · 2017 · Annals of the New York Academy of Sciences
34. Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease
    Zhang, Nicole K., Zhang, Selena K., Zhang, Li I., Tao, Huizhong W., Zhang, Guang-Wei · 2023 · Frontiers in Aging Neuroscience
35. VEGF counteracts amyloid-β-induced synaptic dysfunction
    Laurent Martin, Pauline Bouvet, Naura Chounlamountri, Chantal Watrin, Roger Besançon, Delphine Pinatel, David Meyronet, Jérôme Honnorat, Alain Buisson, Paul Antoine Salin et al. · 2021 · Cell Reports
36. Promising Role of Neuromodulation in Predicting the Progression of Mild Cognitive Impairment to Dementia
    Antonino Naro, Francesco Corallo, Simona De Salvo, Angela Marra, Giuseppe Di Lorenzo, Nunzio Muscarà, Margherita Russo, Silvia Marino, Rosaria De Luca, Placido Bramanti et al. · 2016 · Journal of Alzheimer s Disease
37. Regulation of GABAergic synapse development by postsynaptic membrane proteins
    Wei Lü, Samantha Bromley‐Coolidge, Jun Li · 2016 · Brain Research Bulletin
38. Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors
    Genevieve M. Evin · 2016 · BioDrugs
39. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities
    Shaomin Li, Andrew M. Stern · 2022 · Molecular Psychiatry
40. Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation
    Claudia García‐Rodríguez, Paula Mujica, Javiera Illanes-González, Araceli López, Camilo Vargas, Juan Carlos Sáez, Arlek M. González‐Jamett, Álvaro O. Ardiles · 2023 · Biomedicines
41. Age-related alterations in human neocortical plasticity
    Meg J. Spriggs, Claire J. Cadwallader, Jordan P. Hamm, Lynette J. Tippett, Ian J. Kirk · 2016 · Brain Research Bulletin
42. Proteomic analysis of postsynaptic density in Alzheimer's Disease
    Jianying Zhou, Drew R. Jones, Duc Minh Duong, Allan I. Levey, James J. Lah, Junmin Peng · 2013 · Clinica Chimica Acta
43. Disruption of a Neural Microcircuit in the Rod Pathway of the Mammalian Retina by Diabetes Mellitus
    Áurea Castilho, António Francisco Ambrósio, Espen Hartveit, Margaret Lin Veruki · 2015 · Journal of Neuroscience
44. LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses
    Wang, Shao-hua, Huang, Yan, Yuan, Yang, Xia, Wen-qing, Wang, Pin, Huang, Rong · 2014 · Lipids in Health and Disease
45. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Renu Sharma, Abhishek Shrivastava, Rashmi K. Ambasta, Pravir Kumar · 2016 · Journal of Alzheimer s Disease
46. Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo
    Tomáš Ondrejčák, Neng‐Wei Hu, Yingjie Qi, Igor V. Klyubin, Grant T. Corbett, Graham Mathew Fraser, Michael S. Perkinton, Dominic M. Walsh, Andrew Billinton, Michael J. Rowan · 2019 · Neurobiology of Disease
47. Stereo-seq of the prefrontal cortex in aging and Alzheimer’s disease
    Yun Gong, Mohammad Haeri, Xiao Zhang, Yisu Li, Anqi Liu, Di Wu, Qi‐Lei Zhang, S. Michal Jazwinski, Xiang Zhou, Xiaoying Wang et al. · 2025 · Nature Communications
48. Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression
    Raphael Hesse, Ludwig M. Lausser, Pauline Gummert, Florian Schmid, Anke Wahler, Cathrin Schnack, Katja S. Kroker, Markus Otto, Hayrettin Tumani, Hans Armin Kestler et al. · 2017 · Alzheimer s Research & Therapy
49. Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of A lzheimer's Disease
    Nibaldo C. Inestrosa, Juvenal A. Ríos, Pedro Cisternas, Cheril Tapia‐Rojas, Daniela S. Rivera, Nady Braidy, Juan Manuel Zolezzi, Juan Alejandro Godoy, Francisco J. Carvajal, Álvaro O. Ardiles et al. · 2014 · Brain Pathology
50. Recent Developments in Understanding Brain Aging: Implications for Alzheimer’s Disease and Vascular Cognitive Impairment
    Ferenc Deák, Willard M. Freeman, Zoltan I. Ungvari, Anna Csiszár, William Edmund Sonntag · 2015 · The Journals of Gerontology Series A
51. PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy
    Joseph Benetatos, Rachel E. Bennett, Harrison Tudor Evans, Sevannah A. Ellis, Bradley T. Hyman, Liviu‐Gabriel Bodea, Jürgen Götz · 2020 · Acta Neuropathologica
52. d-Polyglutamine Amyloid Recruits l-Polyglutamine Monomers and Kills Cells
    Karunakar Kar, Irene Arduini, Kenneth W. Drombosky, Patrick C.A. van der Wel, Ronald B. Wetzel · 2013 · Journal of Molecular Biology
53. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin
    K. Rejdak, H. Sienkiewicz-Jarosz, P. Bieńkowski, A. Alvarez · 2023 · Medicinal research reviews (Print)
54. Amyloid‐β oligomers interact with neurexin and diminish neurexin‐mediated excitatory presynaptic organization
    Naito, Yusuke, Tanabe, Yuko, Lee, Alfred Kihoon, Hamel, Edith, Takahashi, Hideto · 2017 · Scientific Reports
55. Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
    Yixiu Zhou, Yuhui Sun, Quanhong Ma, Yaobo Liu · 2018 · Cell Stress
56. X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide
    Kelly L. Summers, Kevin M. Schilling, Graham P. Roseman, Kate A. Markham, Natalia V. Dolgova, Thomas Kröll, Dimosthenis Sokaras, Glenn L. Millhauser, Ingrid J. Pickering, Graham Neil George · 2019 · Inorganic Chemistry
57. Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer’s disease
    Markel Olabarria, Silvia Pasini, Carlo Corona, Pablo A. Robador, Cheng Song, Hardik Patel, Roger Lefort · 2019 · Communications Biology
58. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells
    Jia-Mou Ren, Shu-Li Zhang, Xiaoling Wang, Zhi‐Zhong Guan, Xiaolan Qi · 2020 · Molecular Medicine Reports
59. Synaptic Communication Engineering for Future Cognitive Brain–Machine Interfaces
    Mladen Veletić, Ilangko Balasingham · 2019 · Proceedings of the IEEE
60. Advances in stem cell therapy in Alzheimer’s disease: a comprehensive clinical trial review
    Nikolaos Karvelas, Samuel Bennett, Georgios Politis, Nikolaos-Iasonas Kouris, Christo Kole · 2022 · Stem Cell Investigation
61. Natural Phyto-Antioxidant Albumin Nanoagents to Treat Advanced Alzheimer’s Disease
    Yan Dou, Dongju Zhao, Fan Yang, Yuqing Tang, Jin Keun Chang · 2021 · ACS Applied Materials & Interfaces
62. Fmr1 KO and Fenobam Treatment Differentially Impact Distinct Synapse Populations of Mouse Neocortex
    Gordon X. Wang, Stephen J Smith, Philippe Mourrain · 2014 · Neuron
63. Genetic underpinnings in Alzheimer’s disease – a review
    Ahmed A. Moustafa, Mubashir Hassan, Doaa H. Hewedi, Iman H. Hewedi, Julia K. Garami, Hany Alashwal, Nazar Zaki, Sung‐Yum Seo, Vassilis Cutsuridis A, Sergio L. Angulo et al. · 2017 · Reviews in the Neurosciences
64. Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
    Sofia Essayan-Perez, Bo Zhou, Amber M. Nabet, Marius Wernig, Yu‐Wen Alvin Huang · 2019 · Neurobiology of Disease
65. Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease
    Jonathan Mauricio Muñoz-Cabrera, Adrián Gabriel Sandoval-Hernández, Andrea Niño, Tatiana Báez, Angie Bustos-Rangel, Gloria Patricia Cardona‐Gómez, Alejandro Múnera, Gonzálo Arboleda · 2019 · PLoS ONE
66. Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease
    Guillaume Tremblay, Joël Rousseau, Cedric Happi Mbakam, Jacques P. Tremblay · 2022 · The CRISPR Journal
67. Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
    Paul A. Rowley, Alexey A. Samsonov, Tobey J. Betthauser, Ali Pirasteh, Sterling C. Johnson, Laura B. Eisenmenger · 2020 · Seminars in Ultrasound CT and MRI
68. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers
    Jessica Vargas, Juan Ahumada, Macarena S. Arrázola, Marco Fuenzalida, Nibaldo C. Inestrosa · 2014 · Experimental Neurology
69. Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
    Patricia Regan, Paula L. McClean, Thomas J. Smyth, Margaret Doherty · 2019 · Medicines
70. Altered synaptobrevin-II trafficking in neurons expressing a synaptophysin mutation associated with a severe neurodevelopmental disorder
    Callista B. Harper, Grazia M. S. Mancini, Marjon van Slegtenhorst, Michael Alan Cousin · 2017 · Neurobiology of Disease
71. Experience-dependent structural plasticity targets dynamic filopodia in regulating dendrite maturation and synaptogenesis
    Chengyu Sheng, Uzma Javed, Mary Gibbs, Caixia Long, Jun Yin, Bo Qin, Quan Yuan · 2018 · Nature Communications
72. Promoter DNA hypermethylation – Implications for Alzheimer’s disease
    Yiyuan Liu, Minghui Wang, Edoardo M. Marcora, Bin Zhang, Alison Goate · 2019 · Neuroscience Letters
73. Tissue Clearing and Expansion Methods for Imaging Brain Pathology in Neurodegeneration: From Circuits to Synapses and Beyond
    Arnaldo Parra‐Damas, Carlos A. Saura · 2020 · Frontiers in Neuroscience
74. Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer’s Disease
    Serena Marcelli, Elena Ficulle, Filomena Iannuzzi, Enikò Kövari, Robert Nisticò, Marco Feligioni · 2016 · Molecular Neurobiology
75. Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold
    Frederik Börgel, Fabian Galla, Kirstin Lehmkuhl, Dirk Schepmann, Simon Mensah Ametamey, Bernhard Wünsch · 2019 · Journal of Pharmaceutical and Biomedical Analysis
76. Acute Pannexin 1 Blockade Mitigates Early Synaptic Plasticity Defects in a Mouse Model of Alzheimer’s Disease
    Carolina Flores‐Muñoz, Bárbara Gómez, Elena Mery, Paula Mujica, Ivana Gajardo, Claudio Córdova, Daniela López-Espíndola, Claudia A. Duran-Aniotz, Claudio A. Hetz, Pablo Muñoz et al. · 2020 · Frontiers in Cellular Neuroscience
77. Histone Deacetylases 1 and 2 in Memory Function
    Pao, Ping-Chieh, Tsai, Li-Huei · 2022 · ACS Chemical Neuroscience
78. Reelin proteolysis affects signaling related to normal synapse function and neurodegeneration
    Lussier, April L., Weeber, Edwin J., Rebeck, G. William · 2016 · Frontiers in Cellular Neuroscience
79. The glutamatergic synapse: a complex machinery for information processing
    Vito Di Maio · 2021 · Cognitive Neurodynamics
80. Long non-coding RNAs in Alzheimer's disease
    Zijian Zhang · 2015 · Current Topics in Medicinal Chemistry
81. Multi-site dynamic recording for Aβ oligomers-induced Alzheimer's disease in vitro based on neuronal network chip
    Fan Gao, Keqiang Gao, Chuanjiang He, Mengxue Liu, Hao Wan, Ping Wang · 2019 · Biosensors and Bioelectronics
82. Generation of multi-innervated dendritic spines as a novel mechanism of long-term memory formation
    Karl-Peter Giese, Wajeeha Aziz, Igor Kraev, Michael G. Stewart · 2015 · Neurobiology of Learning and Memory
83. Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline
    Guoyu Lan, Anqi Li, Zhen Liu, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Alzheimer s & Dementia
84. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease
    Cailin Wang, Yanmin Chang, Jiahui Zhu, Yanqing Wu, Xingjun Jiang, Siyi Zheng, Gang Li, Rong Ma · 2023 · Experimental Neurology
85. Centaurin-α1-Ras-Elk-1 Signaling at Mitochondria Mediates β-Amyloid-Induced Synaptic Dysfunction
    Erzsebet M. Szatmari, Ana F. Oliveira, Elizabeth Johnson Sumner, Ryohei Yasuda · 2013 · Journal of Neuroscience
86. PGE 2 -EP3 signaling pathway impairs hippocampal presynaptic long-term plasticity in a mouse model of Alzheimer's disease
    Vincent Maingret, Gaël Barthet, Séverine Deforges, Nan Jiang, Christophe Mulle, Thierry Amédée · 2016 · Neurobiology of Aging
87. Treadmill Exercise Reduces Neuroinflammation, Glial Cell Activation and Improves Synaptic Transmission in the Prefrontal Cortex in 3 × Tg-AD Mice
    Lianwei Mu, Dongdong Xia, Jiajia Cai, Boya Gu, Xiaojie Liu, Vladislav Friedman, Qing-song Liu, Li Zhao · 2022 · International Journal of Molecular Sciences
88. A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies
    Tanja J. de Rijke, M. H. Edwina Doting, Saskia van Hemert, Peter Paul De Deyn, Barbara C. Van Munster, Hermie J. M. Harmsen, Iris E. Sommer · 2022 · Frontiers in Psychiatry
89. Amyloid Beta-Protein and Neural Network Dysfunction
    Fernando Peña‐Ortega · 2013 · Journal of Neurodegenerative Diseases
90. Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology
    Yanghui Sheng, Lei Zhang, Susan C. Su, Li‐Huei Tsai, Jie Zhu · 2015 · Cerebral Cortex
91. Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
    Xiaoyu Zhang, Chuanying Chen, Yi Liu · 2024 · Alzheimer s Research & Therapy
92. Revealing excitation-inhibition imbalance in Alzheimer’s disease using multiscale neural model inversion of resting-state functional MRI
    Guoshi Li, Li‐Ming Hsu, Ye Wu, Andrea Bozoki, Yen‐Yu Ian Shih, Pew‐Thian Yap · 2025 · Communications Medicine
93. Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
    Riyadi Sumirtanurdin, Amirah Y Thalib, Kelvin Cantona, Rizky Abdulah · 2019 · Clinical Interventions in Aging
94. Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer’s Disease Patients Alter Calcium Homeostasis
    Fanny Rubio-Moscardó, Núria Setó‐Salvia, Marta Pera, Mònica Bosch-Morató, Cristina Plata, Olivia Belbin, Gemma G. Gené, Oriol Dols‐Icardo, Martin Ingelsson, Seppo Helisalmi et al. · 2013 · PLoS ONE
95. Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection
    Fanny C.F. Ip, Wing‐Yu Fu, Elaine YL Cheng, Estella P.S. Tong, Ka-Chun Lok, Yan Liang, Wen‐Cai Ye, Nancy Y. Ip · 2015 · Neuropsychopharmacology
96. A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
    Christopher H. van Dyck, Adam P. Mecca, Ryan S. O’Dell, Hugh H. Bartlett, Nina G. Diepenbrock, Yiyun Henry Huang, Mary E. Hamby, Michael Grundman, Susan M. Catalano, Anthony O. Caggiano et al. · 2024 · Alzheimer s Research & Therapy
97. Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease
    Chris G. Parsons, Gerhard Rammes · 2017 · Expert Opinion on Investigational Drugs
98. Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer’s Disease
    Daisuke Ibi, Kazuki Hirashima, Yuya Kojima, Kahori Sumiya, Sari Kondo, Mirai Yamamoto, Toshihiro Ando, Masayuki Hiramatsu · 2020 · Journal of Alzheimer s Disease
99. Levetiracetam Treatment Normalizes Levels of Presynaptic Endocytosis Machinery and Restores Nonamyloidogenic APP Processing in App Knock-in Mice
    Nalini R. Rao, Jeffrey N. Savas · 2021 · Journal of Proteome Research
100. Role of ASIC1a in Aβ-induced synaptic alterations in the hippocampus
     Dalila Mango, Robert Nisticò · 2018 · Pharmacological Research